Pioneering senescence-driven AI technology to predict health and biological aging to guide treatment decisions with unprecedented accuracy.
Our proprietary machine learning algorithms analyze cellular senescence patterns to identify early disease markers and inform treatment strategies.
Utilizing cutting-edge technology to identify and analyze key biomarkers associated with disease risk and treatment responsiveness.
Custom risk profiles and treatment recommendations generated from individual health profiles for optimal patient outcomes.
Senescope is transforming health risk assessment through cutting-edge senescence prediction technology. By integrating advanced artificial intelligence with deep biological expertise, we overcome the limitations of traditional methods to deliver precise, scalable, and accessible solutions for early disease detection and treatment guidance.
Our mission is to enhance lives by empowering clinicians and patients with actionable insights. Founded by a team of visionary healthcare entrepreneurs and AI experts, we leverage our innovative AI platform to analyze complex biological data, uncovering subtle patterns that enable risk prediction, often years before symptoms emerge. Using standard clinical samples, our automated technology rapidly quantifies senescence biomarkers, making advanced diagnostics widely available.
Senescope is redefining how senescence is detected, driving personalized treatment strategies that optimize outcomes and minimize side effects. Join us in revolutionizing healthcare through early detection and precision medicine.
Our groundbreaking research using AI with tissue images as a biomarker of senescence.
AI-driven models to determine cancer risk in healthy women.
Identify senescence response to NR treatment in COPD patients using sputum.
Cancer risk prediction in women with benign breast disease (BBD).
Investigating the role of aging and altitude on senescence in blood smears.